|
| |
VIM
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 18219106 |
Primary colorectal carcinomas display aberrant expression of vimentin, and have activated Notch and TGFbeta signaling pathways. |
| 17960581 |
Rults indicate that cysteine 328 in vimention is the main site for prostaglandin PGA(1) addition. |
| 17719575 |
The suppression of vimentin expression by ras, and the relief of this suppression by TGFbeta, occurs in a promoter-independent fashion, possibly through sequences in the first or second intron. |
| 17663720 |
ZBP-89 functions as a repressor by recruiting HDAC1 to the vimentin promoter. |
| 17652163 |
The nestin(-) vimentin(+) fibroblasts may represent a novel type of multipotent adult stem cells in human dermis. |
| 17476115 |
Vimentin is a major arterial substrate for transglutaminases.Transglutaminase-mediated vimentin dimerization produces a novel unifying pathway by which vasodilatory and remodeling responses may be regulated. |
| 17585878 |
In conclusion, ablation of vimentin expression inhibits migration and invasion of colon and breast cancer cell lines. |
| 15255035 |
It is unlikely that ependymal vimentin is directly involved in the pathogenesis of Chiari II malformation, but may reflect a secondary upregulation due to defective expression of another gene. |
| 12169273 |
Menin's interaction with glial fibrillary acidic protein and vimentin suggests a role for the intermediate filament network in regulating menin activity. |
| 16365157 |
Apoptotic neutrophils express vimentin on their surface; these cells may participate in the development of autoantibodies directed against cytoskeletal proteins, a condition frequently reported in several inflammatory diseases. | →View more information from publications. |
Recent Publications on VIM: |  |
The 2007 International Vocabulary of Metrology (VIM), JCGM 200:2008 [ISO/IEC Guide 99]: Meeting the need for intercontinentally understood concepts and their associated intercontinentally agreed terms.
Unambiguous and consistent concepts and terms such as measurand,... | 30th October, 2009
|
| Clin Biochem. 2009 Mar;42(4-5):246-8.
DOI Direct Link |
Epithelial-mesenchymal transition with expression of SNAI1-induced chemoresistance in colorectal cancer.
BACKGROUND: Previous reports have demonstrated that SNAI1 plays a role in... | 29th October, 2009
| Department of Gastroenterological Surgery, Osaka University Graduate
| Biochem Biophys Res Commun. 2009 Oct 25.
DOI Direct Link |
[Treatment of aggressive non-Hodgkin's lymphomas]
Aggressive non-Hodgkin's lymphomas (NHL) in localized stages I and II,... | 29th October, 2009
| Servicio de Oncologia Medica, Hospital Universitario Virgen del Rocio,
| Rev Clin Esp. 2009 Feb;209(2):88-92.
|
Resistance to carbapenems among Pseudomonas aeruginosa isolated from patients of transplant wards.
BACKGROUND: The aim of the study was to estimate the carbapenems... | 28th October, 2009
| Department of Medical Microbiology, Transplantology and Internal Diseases
| Transplant Proc. 2009 Oct;41(8):3258-60.
DOI Direct Link |
miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
MicroRNAs (miRNAs) are a class of small non-coding RNAs that, in general,... | 22nd October, 2009
| Department of Molecular Cytogenetics, Medical Research Institute and
| Carcinogenesis. 2009 Oct 20.
DOI Direct Link |
→View more research publications. |
Press Releases on VIM:
|
 |
| PDI Reports 2009 Third Quarter Financial Results |
5th November, 2009 |
PDI, Inc. |
SADDLE RIVER, N.J., Nov. 5 /PRNewswire-FirstCall/ -- PDI, Inc. (Nasdaq: PDII), a leading provider of sales and marketing support to U.S. pharmaceutical
|
VIM results (if any) from reagent suppliers |
| Search Bioportfolio and other Life Science Sites for VIM,
or search for VIM on BioPortfolio's antibody search engine. This page has been viewed 591 times Recent Search Terms used to find this page: Vimentin and TGF beta | vimentin Gene-GeneCards | VIM type metallo beta lactamases in Australia MJA | Vimentin Signal Pathways | vimentin pathway | vimentin VIM.13.2 | vim cancer search | vimentin 2009 | vimentin VIM 13.2 antibody | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|